American Professional Society of ADHD and Related Disorders

American Professional Society of ADHD and Related Disorders
World-renowned experts will gather in Washington, DC January 12-14, 2018, at the annual meeting of The American Professional Society for ADHD and Related Disorders to discuss the latest in the guidelines and treatment of attention-deficit/hyperactivity disorder in diverse patient populations. Sign up for our daily e-mail blasts on our registration page, and check back here during the conference for the full coverage of the 2018 APSARD Annual Meeting: ADHD: Evolving Perspectives.
February 19, 2018
How can prescribers and other clinicians collaborate in order to help improve adherence to treatment to manage attention-deficit/hyperactivity disorder (ADHD)? And what keeps patients and their families from adhering to medication?
February 13, 2018
The prevalence of attention-deficit/hyperactivity disorder (ADHD) identified in an outpatient sample of 492 adults seeking mental health treatment was nearly 10 times higher than the prevalence identified in epidemiological studies, according to a poster presented at the recent 2018 Annual Meeting of The American Professional Society of ADHD and Related Disorders.
January 19, 2018
Attention-deficit/hyperactivity disorder (ADHD) is a recognized disorder affecting both children and adults, but what is known about ADHD when it affects older adults, especially those nearing retirement age or those who are already retired? Kathleen G. Nadeau, PhD, is surveying this special population for research for an upcoming book. Nadeau, a psychologist in Maryland, spoke about this issue at the 2018 annual meeting of the American Professional Society of ADHD and Related Disorders.
January 15, 2018
Can improved research designs answer questions that come up between doctors and patients, like better understanding the risks and benefits of prescription medicine for attention-deficit/hyperactivity disorder (ADHD)? Brian M. D'Onofrio, PhD, presented about translational epidemiology in a talk called The Risks and Benefits of ADHD: A Pharmacoepidemiologic Perspecitive to answer those questions at the 2018 annual meeting of the American Professional Society of ADHD and Related Disorders (APSARD).
January 15, 2018
Psychologist J. Russell Ramsay, PhD, presented at the 2018 annual meeting of the American Professional Society of ADHD and Related Disorders about his model for understanding and treating adult attention-deficit/hyperactivity disorder (ADHD) with cognitive-behavioral therapy (CBT) in his session, "Intentions into Actions: CBT for Adult ADHD."
January 14, 2018
During the welcome and opening plenary session of the annual meeting of the American Professional Society of ADHD and Related Disorders (APSARD), 3 speakers gave an overview of different models of cognitive and neural processes that underlie the symptoms, impairments, and medication treatment models of attention-deficit/hyperactivity disorder (ADHD).
January 14, 2018
Using a large database created by a center for actuarial studies, a psychologist and researcher is positing that people with the worst cases of attention-deficit/hyperactivity disorder (ADHD) will see a 25-year reduction in life expectancy, according to a presentation made Saturday at the annual meeting of the American Professional Society of ADHD and Related Disorders.
January 13, 2018
A large proportion of caregivers with children and adolescents diagnosed with attention-deficit/hyperactivity-disorder (ADHD) perceived that the burden of illness remained high even if the children are on current prescription drug therapy, according to a poster presented at the 2018 Annual Meeting of The American Professional Society of ADHD and Related Disorders in Washington, DC.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.